Animal models of liver regeneration

Biomaterials

Volumn 25, Issue 9, 2004, Pages 1601-1611

  Palmes, Daniel ^a   Spiegel, Hans Ullrich ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Animal models; Liver regeneration; Tissue engineering

Indexed keywords

BIOLOGICAL ORGANS; CELLS; DISEASES; PATIENT TREATMENT; PHYSIOLOGICAL MODELS; TISSUE; TRANSPLANTATION (SURGICAL);

TISSUE ENGINEERING;

BIOMATERIALS;

PARACETAMOL; TOXIN;

CELL PROLIFERATION; CHRONIC LIVER DISEASE; DRUG INTOXICATION; EXPERIMENTAL ANIMAL; HEPATITIS; HUMAN; LIVER CELL DAMAGE; LIVER CIRRHOSIS; LIVER FAILURE; LIVER HYPERPLASIA; LIVER INJURY; LIVER REGENERATION; LIVER SURGERY; LIVER TOXICITY; LIVER TRANSPLANTATION; NONHUMAN; PARTIAL HEPATECTOMY; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TISSUE ENGINEERING;

ANIMALIA;

EID: 0346494264     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(03)00508-8     Document Type: Article

References (86)

1. Bader A. Intersections of reconstructive surgery in the area of regenerative medicine [German]. Chirurg. 73:2002;428-434.
2. Schuppan D., Ruehl M., Somasundaram R., Hahn E.G. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis. 21:2001;351-372.
3. Emond J.C., Whitington P.F., Broelsch C.E. Overview of reduced-size liver transplantation. Clin Transplant. 5:1991;168-173.
4. Broelsch C.E., Emond J.C., Whitington P.F., Thistlethwaite J.R., Baker A.L., Lichtor J.L. Application of reduced-size liver transplants as split grafts, auxiliary orthotopic grafts, and living related segmental transplants. Ann Surg. 212:1990;368-375.
5. Inomata Y., Kiuchi T., Kim I., Uemoto S., Egawa H., Asonuma K., Fujita S., Hayashi M., Tanaka K. Auxiliary partial orthotopic living donor liver transplantation as an aid for small-for-size grafts in larger recipients. Transplantation. 67:1999;1314-1319.
6. Palmes D., Qayumi A.K., Spiegel H.U. Liver bridging techniques in the treatment of acute liver failure. J Invest Surg. 13:2000;299-311.
7. Rozga J. Animal models of liver regeneration. Souba W.W., Wilmore D.W. Surgical Research. 2001;703-707 Academic Press, San Diego.
8. Zimmermann A. Liver regeneration: the emerge of new pathways. Med Sci Monit 2002;8:RA 53-63.
9. Court F.G., Wemyss-Holden S.A., Dennison A.R., Maddern G.J. The mystery of liver regeneration. Br J Surg. 89(9):2002;1089-1095.
10. LaBrecque D.R., Feigenbaum A., Bachur N.R. Diurnal rhythm. Effects on hepatic regeneration and hepatic regenerative stimulator substance. Science. 10(199):1978;1082-1084.
11. Diehl A.M. Nutrition, hormones, metabolism, and liver regeneration. Semin Liver Dis. 11:1991;315-320.
12. Moolten F.L., Oakman N.J., Bucher N.L. Accelerated response of hepatic DNA synthesis to partial hepatectomy in rats pretreated with growth hormone or surgical stress. Cancer Res. 30:1970;2353-2357.
13. Czaja M.J. Liver regeneration following hepatic injury. Strain A.J., Diehl A.M. Liver growth and repair. 1998;28-49 Chapman and Hall, London.
14. Higgins G.M., Anderson R.M. Experimental pathology of the liver. I. restoration of the liver of the white rat following partial surgical removal Arch Pathol. 12:1931;186-202.
15. Emond J.C., Renz J.F., Ferrell L.D., Rosenthal P., Lim R.C., Roberts J.P., Lake J.R., Ascher N.L. Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg. 224:1996;544-552.
16. Sakamoto T., Ezure T., Lunz J., Murase N., Tsuji H., Fung J.J., Demetris A.J. Concanavalin A simultaneously primes liver hematopoietic and epithelial progenitor cells for parallel expansion during liver regeneration after partial hepatectomy in mice. Hepatology. 32:2000;256-267.
17. Ku Y., Tominaga M., Sugimoto T., Iwasaki T., Fukumoto T., Takahashi T., Suzuki Y., Kuroda Y. Preoperative hepatic venous embolization for partial hepatectomy combined with segmental resection of major hepatic vein. Br J Surg. 89:2002;63-69.
18. Kahn D., Hickman R., Terblanche J. A porcine model for the study of liver regeneration. J Invest Surg. 1:1988;139-142.
19. Kahn D., Hickman R., Terblanche J., von Sommoggy S. Partial hepatectomy and liver regeneration in pigs - the response to different resection sizes. J Surg Res. 45:1988;176-180.
20. Gaglio P.J., Liu H., Dash S., Cheng S., Dunne B., Ratterree M., Baskin G., Blanchard J., Bohm R., Theise N.D., LaBrecque D. Liver regeneration investigated in a non-human primate model (Macaca mulatta). J Hepatol. 37:2002;625-632.
21. Frerichs FT. Klinik der Leberkrankheiten [German]. Braunschweig 1861, Auflage 2.
22. Rozga J., Jeppsson B., Bengmark S. Portal branch ligation in the rat. Reevaluation of a model. Am J Pathol. 125:1986;300-308.
23. Grisham J.W., Leong G.F., Albright M.L., Emerson J.D. Effect of exchange transfusion on labeling of nuclei with thymidine-3-H and on mitosis in hepatocytes of normal and regenerating rat liver. Cancer Res. 26:1966;1476-1485.
24. Weinbren K., Tarch E. The mitotic response in the rat liver after different regenerative stimuli. Br J Exp Pathol. 45:1964;475-480.
25. Ueno S., Aikou T., Tanabe G., Kobayashi Y., Hamanoue M., Mitsue S., Kawaida K., Nakamura T. Exogenous hepatocyte growth factor markedly stimulates liver regeneration following portal branch ligation in dogs. Cancer Chemother Pharmacol. 38:1996;233-237.
26. Lee Y.W. Pulsed Doppler ultrasonographic evaluation of portal blood flow in dogs with experimental portal vein branch ligation. J Vet Med Sci. 61:1999;59-61.
27. Ichikawa H., Yamanaka K., Tobe T., Mizumoto R. Bile secretion in regenerating liver - a comparison of hepatic resection and ligation of the portal vein branch in dogs. Gastroenterol Jpn. 19:1984;320-327.
28. Nishida M., Yano K., Murakami T., Suzuki T. Introduction of monoclonal antibodies to bromodeoxyuridine to monitor hepatic regeneration. Gastroenterology. 100:1991;1135-1137.
29. Krupski G., Broring D.C., Wittkugel O., Muller L., Nicolas V., Rogiers X., Adam G., Bucheler E. Formation of portal venous collaterals after ligation of the portal vein for induction of liver regeneration [German]. Rofo Fortschr Geb Rontgenstr Neuen Bildgeb Verfahr. 174:2002;1281-1284.
30. Iwakiri Y., Cadelina G., Sessa W.C., Groszmann R.J. Mice with targeted deletion of eNOS develop hyperdynamic circulation associated with portal hypertension. Am J Physiol Gastrointest Liver Physiol. 283:2002;G1074-G1081.
31. Murphy S.T., Ellison G.W., Long M., Van Gilder J. A comparison of the Ameroid constrictor versus ligation in the surgical management of single extrahepatic portosystemic shunts. J Am Anim Hosp Assoc. 37:2001;390-396.
32. Meyer H.P., Rothuizen J., van Sluijs F.J., Voorhout G., van den Brom W.E. Progressive remission of portosystemic shunting in 23 dogs after partial closure of congenital portosystemic shunts. Vet Rec. 144:1999;333-337.
33. Columbano A., Shinozuka H. Liver regeneration versus direct hyperplasia. FASEB J. 10:1996;1118-1128.
34. Shinozuka H., Kubo Y., Katyal S.L., Coni P., Ledda-Columbano G.M., Columbano A., Nakamura T. Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate. Lab Invest. 71:1994;35-41.
35. Ledda-Columbano G.M., Columbano A., Cannas A., Simbula G., Okita K., Kayano K., Kubo Y., Katyal S.L., Shinozuka H. Dexamethasone inhibits induction of liver tumor necrosis factor-alpha mRNA and liver growth induced by lead nitrate and ethylene dibromide. Am J Pathol. 145:1994;951-958.
36. Kubo Y., Yasunaga M., Masuhara M., Terai S., Nakamura T., Okita K. Hepatocyte proliferation induced in rats by lead nitrate is suppressed by several tumor necrosis factor alpha inhibitors. Hepatology. 23:1996;104-114.
37. Nostrant T.T., Miller D.L., Appelman H.D., Gumucio J.J. Acinar distribution of liver cell regeneration after selective zonal injury in the rat. Gastroenterology. 75:1978;181-186.
38. Bruccoleri A., Gallucci R., Germolec D.R., Blackshear P., Simeonova P., Thurman R.G., Luster M.I. Induction of early immediate genes by tumor necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity. Hepatology. 25:1997;133-141.
39. Liu K.X., Kato Y., Yamazaki M., Higuchi O., Nakamura T., Sugiyama Y. Decrease in the hepatic clearance of hepatocyte growth factor in carbon tetrachloride-intoxicated rats. Hepatology. 17:1993;651-660.
40. Lindroos P.M., Zarnegar R., Michalopoulos G.K. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology. 13:1991;743-750.
41. McLean A.E., Verschuuren H.G. Effects of diet and microsomal enzyme induction on the toxicity of dimethyl nitrosamine. Br J Exp Pathol. 50:1969;22-25.
42. Alp M.H., Hickman R. The effect of prostaglandins, branched-chain amino acids and other drugs on the outcome of experimental acute porcine hepatic failure. J Hepatol. 4:1987;99-107.
43. Decker K., Keppler D. Galactosamine induced liver injury. Prog Liver Dis. 4:1972;183-199.
44. Grun M., Liehr H., Rasenack U. Significance of endotoxaemia in experimental "galactosamine-hepatitis" in the rat. Acta Hepatogastroenterol. 24:1977;64-81.
45. Baumgartner D., LaPlante-O'Neill P.M., Sutherland D.E., Najarian J.S. Effects of intrasplenic injection of hepatocytes, hepatocyte fragments and hepatocyte culture supernatants on D-galactosamine-induced liver failure in rats. Eur Surg Res. 15:1983;129-135.
46. Tracy T.F. Jr., Bailey P.V., Goerke M.E., Sotelo-Avila C., Weber T.R. Cholestasis without cirrhosis alters regulatory liver gene expression and inhibits hepatic regeneration. Surgery. 110:1991;176-182.
47. Blitzer B.L., Waggoner J.G., Jones E.A., Gralnick H.R., Towne D., Butler J., Weise V., Kopin I.J., Walters I., Teychenne P.F., Goodman D.G., Berk P.D. A model of fulminant hepatic failure in the rabbit. Gastroenterology. 74:1978;664-671.
48. Diaz-Buxo J.A., Blumenthal S., Hayes D., Gores P., Gordon B. Galactosamine-induced fulminant hepatic necrosis in unanesthetized canines. Hepatology. 25:1997;950-957.
49. Albrecht J., Hilgier W. Arginine in thioacetamide-induced hepatogenic encephalopathy in rats. activation of enzymes of arginine metabolism to glutamate Acta Neurol Scand. 73:1986;498-501.
50. Maddison J.E., Dodd P.R., Johnston G.A., Farrell G.C. Brain gamma-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma gamma-aminobutyric acid-like activity. Gastroenterology. 93:1987;1062-1068.
51. Rahman T.M., Hodgson H.J. Animal models of acute hepatic failure. Int J Exp Pathol. 81:2000;145-157.
52. Bolesta S., Haber S.L. Hepatotoxicity associated with chronic acetaminophen administration in patients without risk factors. Ann Pharmacother. 36:2002;331-333.
53. Zieve L., Anderson W.R., Dozeman R., Draves K., Lyftogt C. Acetaminophen liver injury. sequential changes in two biochemical indices of regeneration and their relationship to histologic alterations J Lab Clin Med. 105:1985;619-624.
54. Leonard T.B., Morgan D.G., Dent J.G. Ranitidine-acetaminophen interaction. effects on acetaminophen-induced hepatotoxicity in Fischer 344 rats Hepatology. 5:1985;480-487.
55. Francavilla A., Makowka L., Polimeno L., Barone M., Demetris J., Prelich J., Van Thiel D.H., Starzl T.E. A dog model for acetaminophen-induced fulminant hepatic failure. Gastroenterology. 96:1989;470-478.
56. Miller D.J., Hickman R., Fratter R., Terblanche J., Saunders S.J. An animal model of fulminant hepatic failure. a feasibility study Gastroenterology. 71:1976;109-113.
57. Morales-Gonzalez J.A., Gutierrez-Salinas J., Yanez L., Villagomez-Rico C., Badillo-Romero J., Hernandez-Munoz R. Morphological and biochemical effects of a low ethanol dose on rat liver regeneration. role of route and timing of administration Dig Dis Sci. 44:1999;1963-1974.
58. Akerman P.A., Cote P.M., Yang S.Q., McClain C., Nelson S., Bagby G., Diehl A.M. Long-term ethanol consumption alters the hepatic response to the regenerative effects of tumor necrosis factor-alpha. Hepatology. 17:1993;1066-1073.
59. Frank W.O., Rayyes A.N., Washington A., Holt P.R. Effect of acute ethanol administration upon hepatic regeneration. J Lab Clin Med. 93:1979;402-413.
60. Orrego H., Crossley I.R., Saldivia V., Medline A., Varghese G., Israel Y. Long-term ethanol administration and short- and long-term liver regeneration after partial hepatectomy. J Lab Clin Med. 97:1981;221-230.
61. Diehl A.M., Chacon M., Wagner P. The effect of chronic ethanol feeding on ornithine decarboxylase activity and liver regeneration. Hepatology. 8:1988;237-242.
62. Tsukamoto H., Matsuoka M., French S.W. Experimental models of hepatic fibrosis. a review Semin Liver Dis. 10:1990;56-65.
63. Bisgaard H.C., Thorgeirsson S.S. Hepatic regeneration. The role of regeneration in pathogenesis of chronic liver diseases. Clin Lab Med. 16:1996;325-339.
64. Orloff M.J. Portal hypertension and portacaval shunt. Souba W.W., Wilmore D.W. Surgical Research. 2001;637-685 Academic Press, San Diego.
65. Cornelius C.E., Arias I.M. Animal model of human disease. Crigler-Najjar Syndrome. Animal model. hereditary nonhemolytic unconjugated hyperbilirubinemia in Gunn rats Am J Pathol. 69:1972;369-372.
66. Jansen P.L.M., Ouda Elferink R.P.J. Hereditary conjugated hyperbilirubinemia in Wistar rats. a model for the study of ATP-dependent hepatocanalicular organic anion transport Cornelius C.E. Animal models in liver research. Advances in veterinary science and comparative medicine. 1993;175-195 Academic Press, San Diego.
67. Nagase S., Shimamune K., Shumiya S. Albumin-deficient rat mutant. Science. 205(4406):1979;590-591.
68. Watanabe Y. Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). Atherosclerosis. 36:1980;261-268.
69. Provoost A.P., Madern G.C., Sinaasappel M., Terpstra O.T., Molenaar J.C. Successful prolonged correction of an inborn metabolic defect by heterotopic auxiliary liver transplantation in a dog model. Transplant Proc. 25:1993;1950-1951.
70. Voros K., Albert M., Vetesi F., Harmat G., Binder K., Szaniszlo F. Hepatic ultrasonographic findings in experimental carbon tetrachloride intoxication of the dog. Acta Vet Hung. 45:1997;137-150.
71. Kawakami S., Tsubouchi H., Nakagawa S., Hirono S., Arakaki N., Nakamura O., Daikuhara Y., Arima T. Expression of hepatocyte growth factor in normal and carbon tetrachloride-treated monkeys. Hepatology. 20:1994;1255-1260.
72. Koniaris L.G., Zimmers-Koniaris T., Hsiao E.C., Chavin K., Sitzmann J.V., Farber J.M. Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol. 167:2001;399-406.
73. Ho D.W., Fan S.T., To J., Woo Y.H., Zhang Z., Lau C., Wong J. Selective plasma filtration for treatment of fulminant hepatic failure induced by D-galactosamine in a pig model. Gut. 50:2002;869-876.
74. Metzner C., Hartig W., Matkowitz R., Graubaum H.J., Jung K., Wagenknecht C., Ritter R. Value of various amino acid mixtures for the treatment of chronic liver damage [German]. Infusionsther Klin Ernahr. 14:1987;256-260.
75. Gardner C.R., Laskin J.D., Dambach D.M., Sacco M., Durham S.K., Bruno M.K., Cohen S.D., Gordon M.K., Gerecke D.R., Zhou P., Laskin D.L. Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase. potential role of tumor necrosis factor-alpha and interleukin-10 Toxicol Appl Pharmacol. 184:2002;27-36.
76. Shakoori A.R., Cheema I.A., Rani A., Ali S.S. Evaluation of liver function after thioacetamide treatment of partially hepatectomized rabbits. Acta Physiol Pharmacol Latinoam. 34:1984;301-312.
77. Diehl A.M. Effect of ethanol on tumor necrosis factor signaling during liver regeneration. Clin Biochem. 32:1999;571-578.
78. Riordan S.M., Williams R. Extracorporeal support and hepatocyte transplantation in acute liver failure and cirrhosis. J Gastroenterol Hepatol. 14:1999;757-770.
79. Allen J.W., Hassanein T., Bhatia S.N. Advances in bioartificial liver devices. Hepatology. 34:2001;447-455.
80. Liu J., Kjaergard L.L., Als-Nielsen B., Gluud C. Artificial and bioartificial support systems for liver failure. a cochrane hepato-biliary group protocol Liver. 22:2002;433-438.
81. Holzman M.D., Rozga J., Neuzil D.F., Griffin D., Moscioni A.D., Demetriou A.A. Selective intraportal hepatocyte transplantation in analbuminemic and Gunn rats. Transplantation. 55:1993;1213-1219.
82. Asonuma K., Gilbert J.C., Stein J.E., Takeda T., Vacanti J.P. Quantitation of transplanted hepatic mass necessary to cure the Gunn rat model of hyperbilirubinemia. J Pediatr Surg. 27:1992;298-301.
83. Raper S.E., Grossman M., Rader D.J., Thoene J.G., Clark B.J. 3rd, Kolansky D.M., Muller D.W., Wilson J.M. Safety and feasibility of liver-directed ex vivo gene therapy for homozygous familial hypercholesterolemia. Ann Surg. 223:1996;116-126.
84. Fox I.J., Chowdhury J.R., Kaufman S.S., Goertzen T.C., Chowdhury N.R., Warkentin P.I., Dorko K., Sauter B.V., Strom S.C. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med. 338:1998;1422-1426.
85. Langer R., Cima L.G., Tamada J.A., Wintermantel E. Future directions in biomaterials. Biomaterials. 11:1990;738-745.
86. Vacanti J.P., Langer R. Tissue engineering. the design and fabrication of living replacement devices for surgical reconstruction and transplantation Lancet. 354:1999;32-34.